Skip to content
2000
Volume 26, Issue 1
  • ISSN: 1871-5249
  • E-ISSN: 1875-6166

Abstract

The consumption and utilization of leaves and seeds in traditional herbal treatments have left an indelible mark. Their rich chemical makeup and remarkable pharmacological effects, particularly in the form of leaf extracts, have captivated researchers seeking novel treatments for degenerative nerve illnesses like Alzheimer's disease. However, the story of doesn't end there. The seeds, which were once highly regarded as sustenance and medicine but are often overlooked, hold ancient wisdom that awaits discovery and understanding, also, it is advised to consume one to two seeds per day because of the ginkgo toxin side effect. Traditional Chinese medicine has harnessed its potential to combat intestinal tract worm infections, pyogenic skin diseases, enuresis, asthma, cough, and more, owing to its abundant reserves of carbs, protein, fat, and polyphenols. Moreover, recent studies have emerged, suggesting their neuroprotective properties. Fostering awareness and encouraging the consumption of seeds thus becomes paramount. As we embark on a quest to delve into the depths of seeds, this comprehensive review aims to shed light on their key components, bioactivities, processing techniques, and the latest insights into their pharmacological actions. By embracing a holistic understanding of seeds, we lay the foundation for their scientific advancement and the development of this remarkable edible seed. Furthermore, it is essential to acknowledge that while holds immense potential, caution is warranted, as adverse effects such as allergies have been reported, particularly in individuals with known allergies.

Loading

Article metrics loading...

/content/journals/cnsamc/10.2174/0118715249362016250401085542
2025-04-17
2026-02-25
Loading full text...

Full text loading...

References

  1. HansenC. MauleA.F. Pehr Osbeck’s collections and linnaeus’s species plantarum (1753).Bot. J. Linn. Soc.197367318921210.1111/j.1095‑8339.1973.tb01738.x
    [Google Scholar]
  2. CraneP.R. CraneP. Von KnorringP. Ginkgo: The tree that time forgot.Yale University Press2013352
    [Google Scholar]
  3. GoldP.E. CahillL. WenkG.L. Ginkgo biloba: A cognitive enhancer?Psychol. Sci. Public Interest20023121110.1111/1529‑1006.0000626151474
    [Google Scholar]
  4. SinghB. KaurP. Gopichand SinghR.D. AhujaP.S. Biology and chemistry of Ginkgo biloba.Fitoterapia200879640141810.1016/j.fitote.2008.05.00718639617
    [Google Scholar]
  5. HadfieldM.I. Some notes on the Ginkgo.Q. J. For.1960544331337
    [Google Scholar]
  6. PonderHG ShumackRL Liners--the first step in shade tree productionAmerican nurseryman1981
    [Google Scholar]
  7. IsahT. Rethinking Ginkgo biloba L.: Medicinal uses and conservation.Pharmacogn. Rev.201591814014810.4103/0973‑7847.16213726392712
    [Google Scholar]
  8. GunckelJ.E. ThimannK.V. WetmoreR.H. Studies of development in long shoots and short shoots of Ginkgo biloba L. IV. Growth habit, shoot expression, and the mechanism of its control.Am. J. Bot.194936330931610.1002/j.1537‑2197.1949.tb05265.x
    [Google Scholar]
  9. Del TrediciP. The evolution, ecology, and cultivation of Ginkgo biloba. Ginkgo Biloba 2000723
    [Google Scholar]
  10. LaurainD. Cultivation of Ginkgo biloba on a large scale. Ginkgo biloba.Amsterdam, NetherlandsHarwood Academic Publishers20006379
    [Google Scholar]
  11. KosenkoI.S. TsybrovskaN.V. BalabakO.A. HrabovyiV.M. MuzykaH.I. ShvetsT.A. OksantiukV.M. Introduction of Ginkgo biloba L. and its cultivars by vegetative propagation.Ukr. J. Ecol.20211176576
    [Google Scholar]
  12. Hori, T.; Ridge, R.W.; Tulecke, W.; Del Tredici, P.; Trémouillaux-Guiller, J.; Tobe, H., Eds.; Ginkgo biloba is a global treasure: from biology to medicine.Springer Science & Business Media2012
    [Google Scholar]
  13. MauginiE. Anatomical and histological differences between male and female plants of Ginkgo biloba.Giorn Bot Ital.19657223324210.1080/11263506509430827
    [Google Scholar]
  14. TsunamotoY. NaoeS. MasakiT. IsagiY. Different contributions of birds and mammals to seed dispersal of a fleshy-fruited tree.Basic Appl. Ecol.202043667510.1016/j.baae.2019.07.005
    [Google Scholar]
  15. WangD. LuY. ZhangM. LuZ. LuoK. ChengF. WangL. Structure and function of the neck cell during fertilization in Ginkgo biloba L.Trees2014284995100510.1007/s00468‑014‑1013‑2
    [Google Scholar]
  16. LiT.T. ChenS.M. Temperature and the development of the Ginkgo embryo.Sci. Rep. Natl. Tsing Hua Univ., Ser. B. Biol. Sci.193423739
    [Google Scholar]
  17. D’ApiceG. MoschinS. AranitiF. NigrisS. Di MarzoM. MutoA. BanfiC. BrunoL. ColomboL. BaldanB. The role of pollination in controlling Ginkgo biloba ovule development.New Phytol.202123262353236810.1111/nph.1775334558676
    [Google Scholar]
  18. SomaS. In vitro culture of the female gametophyte on the leaf: Trial to get the offspring.Annu. Rep. Fac. Educ.2000134109114
    [Google Scholar]
  19. DeFeudisF.V. Ginkgo biloba extract (EGb761): From chemistry to the clinic.Ullstein MedicalWiesbaden1998
    [Google Scholar]
  20. YoshitakeT. YoshitakeS. KehrJ. The Ginkgo biloba extract EGb 761 ® and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex.Br. J. Pharmacol.2010159365966810.1111/j.1476‑5381.2009.00580.x20105177
    [Google Scholar]
  21. van BeekT.A. Chemical analysis of Ginkgo biloba leaves and extracts.J. Chromatogr. A20029671215510.1016/S0021‑9673(02)00172‑312219929
    [Google Scholar]
  22. RisterR. KleinS. RigginsC. The complete German Commission E. Monographs: Therapeutic guide to herbal medicines.AustinAmerican Botanical Council1998
    [Google Scholar]
  23. NakanishiK. The ginkgolides.Pure Appl. Chem.19671418911410.1351/pac1967140100896036635
    [Google Scholar]
  24. JaraczS. MalikS. NakanishiK. Isolation of ginkgolides A, B, C, J and bilobalide from G. biloba extracts.Phytochemistry200465212897290210.1016/j.phytochem.2004.08.02615501258
    [Google Scholar]
  25. NakanishiK. HabaguchiK. NakadairaY. WoodsM.C. MaruyamaM. MajorR.T. AlauddinM. PatelA.R. WeingesK. BaehrW. Structure of bilobalide, a rare tert-butyl containing sesquiterpenoid related to the C20-ginkgolides.J. Am. Chem. Soc.197193143544354610.1021/ja00743a051
    [Google Scholar]
  26. ZhangZ. Extraction and purification of Ginkgo biloba flavonoids and evaluation of their inhibitory effects on amyloid-β aggregation.Food Funct.2020111798810
    [Google Scholar]
  27. PanzellaL. MocciaF. NastiR. MarzoratiS. VerottaL. NapolitanoA. Bioactive phenolic compounds from agri-food wastes: An update on green and sustainable extraction methodologies.Front. Nutr.202076010.3389/fnut.2020.0006032457916
    [Google Scholar]
  28. ZhangY. HeL. LiQ. ChengJ. WangY. ZhaoJ. YuanS. ChenY. ShiR. Optimization of ultrasonic-assisted deep eutectic solvent for the extraction of polysaccharides from Indocalamus tessellatus leaves and their biological studies.Sustain. Chem. Pharm.20223010085510.1016/j.scp.2022.100855
    [Google Scholar]
  29. ShiJ. ZouX. ZhaoJ. MelH. WangK. WangX. ChenH. Determination of total flavonoids content in fresh Ginkgo biloba leaf with different colors using near infrared spectroscopy.Spectrochim. Acta A Mol. Biomol. Spectrosc.20129427127610.1016/j.saa.2012.03.07822522302
    [Google Scholar]
  30. LiuH. Optimization of the extraction and purification of Ginkgo biloba L flavonoids by macroporous resin and assessment of their antioxidant and anti-inflammatory activities.Molecules201924592830866428
    [Google Scholar]
  31. TaoY. ZhuF. PanM. LiuQ. WangP. Pharmacokinetic, metabolism, and metabolomic strategies provide deep insight into the underlying mechanism of Ginkgo biloba flavonoids in the treatment of cardiovascular disease.Front. Nutr.2022985737010.3389/fnut.2022.85737035399672
    [Google Scholar]
  32. ZhangY. ChenA.Y. LiM. ChenC. YaoQ. Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic cancer cells.J. Surg. Res.20081481172310.1016/j.jss.2008.02.03618570926
    [Google Scholar]
  33. WoelkartK. FeizlmayrE. DittrichP. BeublerE. PinlF. SuterA. BauerR. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans.Phytother. Res.201024344545010.1002/ptr.307420041430
    [Google Scholar]
  34. HanY.S. RoytrakulS. VerberneM.C. van der HeijdenR. LinthorstH.J.M. VerpoorteR. Cloning of a cDNA encoding 1-deoxy-d-xylulose 5-phosphate synthase from Morinda citrifolia and analysis of its expression in relation to anthraquinone accumulation.Plant Sci.2003164691191710.1016/S0168‑9452(02)00362‑X
    [Google Scholar]
  35. ShinB.K. KimM. HanJ. Exceptionally high percentage of IPP synthesis by Ginkgo biloba IspH is mainly due to Phe residue in the active site.Phytochemistry201713691410.1016/j.phytochem.2017.01.01228139297
    [Google Scholar]
  36. EisenreichW. BacherA. ArigoniD. RohdichF. Biosynthesis of isoprenoids via the non-mevalonate pathway.Cell. Mol. Life Sci.200461121401142610.1007/s00018‑004‑3381‑z15197467
    [Google Scholar]
  37. GongY. LiaoZ. GuoB. SunX. TangK. Molecular cloning and expression profile analysis of Ginkgo biloba DXS gene encoding 1-deoxy-D-xylulose 5-phosphate synthase, the first committed enzyme of the 2-C-methyl-D-erythritol 4-phosphate pathway.Planta Med.200672432933510.1055/s‑2005‑91623416557474
    [Google Scholar]
  38. ZengZ. ZhuJ. ChenL. WenW. YuR. Biosynthesis pathways of ginkgolides.Pharmacogn. Rev.2013713475223922456
    [Google Scholar]
  39. RažnáK. SawinskaZ. IvanišováE. VukovicN. TerentjevaM. StričíkM. KowalczewskiP.Ł. HlavačkováL. RovnáK. ŽiarovskáJ. KačániováM. Properties of Ginkgo biloba L.: Antioxidant characterization, antimicrobial activities, and genomic microRNA based marker fingerprints.Int. J. Mol. Sci.2020219308710.3390/ijms2109308732349345
    [Google Scholar]
  40. TanakaK. GaldurózR.F. GobbiL.T. GaldurózJ.C. Ginkgo biloba extract in an animal model of Parkinson’s disease: A systematic review.Curr. Neuropharmacol.201311443043510.2174/1570159X1131104000624381532
    [Google Scholar]
  41. Abdel-ZaherA.O. FarghalyH.S.M. El-RefaiyA.E.M. Abd-EldayemA.M. Protective effect of the standardized extract of ginkgo biloba (EGb761) against hypertension with hypercholesterolemia-induced renal injury in rats: Insights in the underlying mechanisms.Biomed. Pharmacother.20179594495510.1016/j.biopha.2017.08.07828915536
    [Google Scholar]
  42. CastilloE. González-RosendeM.E. Martínez-SolísI. The use of herbal medicine in the treatment of vitiligo: An updated review.Planta Med.202389546848310.1055/a‑1855‑183936379447
    [Google Scholar]
  43. KotakadiV.S. JinY. HofsethA.B. YingL. CuiX. VolateS. ChumanevichA. WoodP.A. PriceR.L. McNealA. SinghU.P. SinghN.P. NagarkattiM. NagarkattiP.S. MatesicL.E. AuclairK. WargovichM.J. HofsethL.J. Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis.Carcinogenesis20082991799180610.1093/carcin/bgn14318567620
    [Google Scholar]
  44. WuY.Z. LiS.Q. ZuX.G. DuJ. WangF.F. Ginkgo biloba extract improves coronary artery circulation in patients with coronary artery disease: contribution of plasma nitric oxide and endothelin‐1.Phytother. Res.200822673473910.1002/ptr.233518446847
    [Google Scholar]
  45. Di MeoF. CucinielloR. MargarucciS. BergamoP. PetilloO. PelusoG. FilosaS. CrispiS. Ginkgo biloba prevents oxidative stress-induced apoptosis blocking p53 activation in neuroblastoma cells.Antioxidants20209427910.3390/antiox904027932224984
    [Google Scholar]
  46. SilvaH. MartinsF. Cardiovascular activity of ginkgo biloba—an insight from healthy subjects.Biology20221211510.3390/biology1201001536671707
    [Google Scholar]
  47. NowakA. KojderK. Zielonka-BrzezickaJ. WróbelJ. BosiackiM. FabiańskaM. WróbelM. Sołek-PastuszkaJ. KlimowiczA. The use of Ginkgo biloba L. as a neuroprotective agent in Alzheimer’s disease.Front. Pharmacol.20211277503410.3389/fphar.2021.77503434803717
    [Google Scholar]
  48. KimS.M. KuzuyamaT. ChangY.J. SongK.S. KimS.U. Identification of class 2 1-deoxy-D-xylulose 5-phosphate synthase and 1-deoxy-D-xylulose 5-phosphate reductoisomerase genes from Ginkgo biloba and their transcription in embryo culture with respect to ginkgolide biosynthesis.Planta Med.200672323424010.1055/s‑2005‑91618016534728
    [Google Scholar]
  49. PietriS. MaurelliE. DrieuK. CulcasiM. Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761).J. Mol. Cell. Cardiol.199729273374210.1006/jmcc.1996.03169140830
    [Google Scholar]
  50. LoH.M. LinF.Y. TsengC.D. ChiangF.T. HsuK.L. TsengY.Z. Effect of EGb 761, a ginkgo biloba extract, on early arrhythmia induced by coronary occlusion and reperfusion in dogs.J. Formos. Med. Assoc.19949375925977866057
    [Google Scholar]
  51. KoltaiM. TosakiA. HosfordD. BraquetP. Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion.Eur. J. Pharmacol.1989164229330210.1016/0014‑2999(89)90470‑62759177
    [Google Scholar]
  52. BastianettoS. ZhengW.H. QuirionR. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: Involvement of its flavonoid constituents and protein kinase C.J. Neurochem.20007462268227710.1046/j.1471‑4159.2000.0742268.x10820186
    [Google Scholar]
  53. ParkH.J. KimM.M. Flavonoids in Ginkgo biloba fallen leaves induce apoptosis through modulation of p53 activation in melanoma cells.Oncol. Rep.201533143343810.3892/or.2014.360225394497
    [Google Scholar]
  54. QinX.F. LuX.J. GeJ.B. XuH.Z. QinH.D. XuF. Ginkgolide B prevents cathepsin-mediated cell death following cerebral ischemia/reperfusion injury.Neuroreport201425426727310.1097/WNR.000000000000009624264075
    [Google Scholar]
  55. NaikS.R. PandaV.S. Antioxidant and hepatoprotective effects of Ginkgo biloba phytosomes in carbon tetrachloride‐induced liver injury in rodents.Liver Int.200727339339910.1111/j.1478‑3231.2007.01463.x17355462
    [Google Scholar]
  56. SatiS.C. JoshiS. Antibacterial activities of Ginkgo biloba L. leaf extracts.ScientificWorldJournal2011112237224210.1100/2011/54542122125471
    [Google Scholar]
  57. MahadevanS. ParkY. Multifaceted therapeutic benefits of Ginkgo biloba L.: Chemistry, efficacy, safety, and uses.J. Food Sci.2008731R14R1910.1111/j.1750‑3841.2007.00597.x18211362
    [Google Scholar]
  58. KangH. Hypocholesterolemia effect of Ginkgo biloba seeds extract from high-fat diet mice.Biomed. Sci. Lett.201723213814310.15616/BSL.2017.23.2.138
    [Google Scholar]
  59. LiuH. PeiX. ShiK. WangJ. HanF. LiA. Effects of replacing wheat flour with detoxified ginkgo nut powder on lipid metabolism of obese C57BL/6J male mice.Food Agric. Immunol.2018291395510.1080/09540105.2017.1358255
    [Google Scholar]
  60. TaysiS. OrkmezM. SaricicekE. DemirE. AdliM. AlB. OkumusS. The effects of oral Ginkgo biloba supplementation on radiation-induced oxidative injury in the lens of rat.Pharmacogn. Mag.201172614114510.4103/0973‑1296.8067321716624
    [Google Scholar]
  61. DongC. Protective effect of extract of Ginkgo biloba 761 against frostbite injury in rats.Plast. Reconstr. Surg.20201454874e10.1097/PRS.000000000000666132221251
    [Google Scholar]
  62. PriyankaA. SindhuG. ShyniG.L. Preetha RaniM.R. NishaV.M. RaghuK.G. Bilobalide abates inflammation, insulin resistance and secretion of angiogenic factors induced by hypoxia in 3T3-L1 adipocytes by controlling NF-κB and JNK activation.Int. Immunopharmacol.20174220921710.1016/j.intimp.2016.11.01927936435
    [Google Scholar]
  63. WangY. WangR. WangY. PengR. WuY. YuanY. Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling.Drug Des. Devel. Ther.201596303631726664050
    [Google Scholar]
  64. WhitingD.R. GuariguataL. WeilC. ShawJ. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030.Diabetes Res. Clin. Pract.201194331132110.1016/j.diabres.2011.10.02922079683
    [Google Scholar]
  65. HuangW.C. ChenY.L. LiuH.C. WuS.J. LiouC.J. Ginkgolide C reduced oleic acid-induced lipid accumulation in HepG2 cells.Saudi Pharm. J.20182681178118410.1016/j.jsps.2018.07.00630532639
    [Google Scholar]
  66. Vaghef-MehrabanyE. MalekiV. BehroozM. RanjbarF. Ebrahimi-MameghaniM. Can psychobiotics “mood” ify gut? An update systematic review of randomized controlled trials in healthy and clinical subjects, on anti-depressant effects of probiotics, prebiotics, and synbiotics.Clin. Nutr.20203951395141010.1016/j.clnu.2019.06.00431307840
    [Google Scholar]
  67. ChenP. HeiM. KongL. LiuY. YangY. MuH. ZhangX. ZhaoS. DuanJ. One water-soluble polysaccharide from Ginkgo biloba leaves with antidepressant activities via modulation of the gut microbiome.Food Funct.201910128161817110.1039/C9FO01178A31742291
    [Google Scholar]
  68. ZhangL. LiuJ. GeY. LiuM. Ginkgo biloba extract reduces hippocampus inflammatory responses, improves cardiac functions and depressive behaviors in a heart failure mouse model.Neuropsychiatr. Dis. Treat.2019153041305010.2147/NDT.S22929631754303
    [Google Scholar]
  69. ShiC. XiaoS. LiuJ. GuoK. WuF. YewD.T. XuJ. Ginkgo biloba extract EGb761 protects against aging-associated mitochondrial dysfunction in platelets and hippocampi of SAMP8 mice.Platelets201021537337910.3109/0953710090351144820459350
    [Google Scholar]
  70. Dal BeloS.E. GasparL.R. Maia CamposP.M.B.G. MartyJ-P. Skin penetration of epigallocatechin-3-gallate and quercetin from green tea and GBEs vehiculated in cosmetic formulations.Skin Pharmacol. Physiol.200922629930410.1159/00024129919786823
    [Google Scholar]
  71. BaliutyteG. TrumbeckaiteS. BanieneR. BorutaiteV. ToleikisA. Effects of standardized extract of Ginkgo biloba leaves EGb761 on mitochondrial functions: mechanism(s) of action and dependence on the source of mitochondria and respiratory substrate.J. Bioenerg. Biomembr.201446649350110.1007/s10863‑014‑9590‑825395298
    [Google Scholar]
  72. ShiC. FangL. YewD.T. YaoZ. XuJ. Ginkgo biloba extract EGb761 protects against mitochondrial dysfunction in platelets and hippocampi in ovariectomized rats.Platelets2010211535910.3109/0953710090339518019938886
    [Google Scholar]
  73. LiuY. LiuY. ZhangW. SunM. WengW. GaoR. Network pharmacology-based strategy to investigate the pharmacological mechanisms of Ginkgo biloba extract for aging.Evid. Based Complement. Alternat. Med.202020201850849110.1155/2020/850849132802136
    [Google Scholar]
  74. KajariaD. TripathiJ. TiwariS. PandeyB. Immunomodulatory effect of ethanolic extract of Shirishadi compound.Ayu201334332232610.4103/0974‑8520.12313624501532
    [Google Scholar]
  75. RenQ. ChenJ. DingY. ChengJ. YangS. DingZ. DaiQ. DingZ. In vitro antioxidant and immunostimulating activities of polysaccharides from Ginkgo biloba leaves.Int. J. Biol. Macromol.201912497298010.1016/j.ijbiomac.2018.11.27630508541
    [Google Scholar]
  76. Noor-E-Tabassum DasR. LamiM.S. ChakrabortyA.J. MitraS. TalleiT.E. IdroesR. MohamedA.A.R. HossainM.J. DhamaK. Mostafa-HedeabG. EmranT.B. Ginkgo biloba: A treasure of functional phytochemicals with multi-medicinal applications.Evid. Based Complement. Alternat. Med.2022202213010.1155/2022/828881835265150
    [Google Scholar]
  77. XuA. RenL. ZhengY. ChenH. Immunomodulatory effect of Ginkgo biloba exocarp polysaccharides on immunosuppressive mice induced by cyclophosphamide.Zhongguo Yaolixue Yu Dulixue Zazhi200822169
    [Google Scholar]
  78. ParsadD. PandhiR. JunejaA. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo.Clin. Exp. Dermatol.200328328528710.1046/j.1365‑2230.2003.01207.x12780716
    [Google Scholar]
  79. ZhangX.Y. ZhangW.F. ZhouD.F. ChenD.C. XiuM.H. WuH.R. HaileC.N. KostenT.A. KostenT.R. Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba.Biol. Psychiatry201272870070610.1016/j.biopsych.2012.04.03222695185
    [Google Scholar]
  80. ZhengW. XiangY.Q. NgC. UngvariG. ChiuH. XiangY.T. Extract of Ginkgo biloba for tardive dyskinesia: Meta-analysis of randomized controlled trials.Pharmacopsychiatry201649310711110.1055/s‑0042‑10288426979525
    [Google Scholar]
  81. ChenX. HongY. ZhengP. Efficacy and safety of extract of Ginkgo biloba as an adjunct therapy in chronic schizophrenia: A systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis.Psychiatry Res.2015228112112710.1016/j.psychres.2015.04.02625980333
    [Google Scholar]
  82. WoelkH. ArnoldtK.H. KieserM. HoerrR. Ginkgo biloba special extract EGb 761® in generalized anxiety disorder and adjustment disorder with anxious mood: A randomized, double-blind, placebo-controlled trial.J. Psychiatr. Res.200741647248010.1016/j.jpsychires.2006.05.00416808927
    [Google Scholar]
  83. MontesP. Ruiz-SanchezE. RojasC. RojasP. Ginkgo biloba extract 761: A review of basic studies and potential clinical use in psychiatric disorders.CNS Neurol. Disord. Drug Targets201514113214910.2174/187152731466615020215144025642989
    [Google Scholar]
  84. NordqvistJ. Health benefits of Gingko biloba.Medical News and Health News.2017201710
    [Google Scholar]
  85. HallJ.E. GrangerJ.P. do CarmoJ.M. da SilvaA.A. DubinionJ. GeorgeE. HamzaS. SpeedJ. HallM.E. Neurophysiology of the cardiovascular system.Compr. Physiol.2012242393244223720252
    [Google Scholar]
  86. Korsager LarsenM. MatchkovV.V. Hypertension and physical exercise: The role of oxidative stress.Medicina2016521192710.1016/j.medici.2016.01.00526987496
    [Google Scholar]
  87. KubotaY. TanakaN. UmegakiK. TakenakaH. MizunoH. NakamuraK. ShinozukaK. KunitomoM. Ginkgo biloba extract-induced relaxation of rat aorta is associated with increase in endothelial intracellular calcium level.Life Sci.200169202327233610.1016/S0024‑3205(01)01303‑011681620
    [Google Scholar]
  88. SpencerJP Flavonoids: Modulators of brain function?Br. J. Nutr.200899E-S1ES60ES7710.1017/S0007114508965776
    [Google Scholar]
  89. SinghS.K. SrivastavS. CastellaniR.J. Plascencia-VillaG. PerryG. Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders.Neurotherapeutics201916366667410.1007/s13311‑019‑00767‑831376068
    [Google Scholar]
  90. NashK.M. ShahZ.A. Current perspectives on the beneficial role of Ginkgo biloba in neurological and cerebrovascular disorders.Integr. Med. Insights201510IMI.S2505410.4137/IMI.S2505426604665
    [Google Scholar]
  91. BarnesD.E. YaffeK. The projected effect of risk factor reduction on Alzheimer’s disease prevalence.Lancet Neurol.201110981982810.1016/S1474‑4422(11)70072‑221775213
    [Google Scholar]
  92. HajirezaeeS. RafieepourA. ShafieiS. RahimiR. Immunostimulating effects of GBE against toxicity induced by organophosphate pesticide, diazinon in rainbow trout, Oncorhynchus mykiss: Innate immunity components and immune-related genes.Environ. Sci. Pollut. Res. Int.20192698798880710.1007/s11356‑019‑04327‑730712205
    [Google Scholar]
  93. Del TrediciP. The architecture of Ginkgo biloba L. L'Arbre.1991Available from: https://www.researchgate.net/profile/Peter-Del-Tredici/publication/286763206_The_architecture_of_Ginkgo_biloba_L/links/597a42590f7e9b0469b234b2/The-architecture-of-Ginkgo-biloba-L.pdf
  94. Effect of EGb761® on brain glucose metabolism in three groups of elderly defined by cognitive function.Available from: https://clinicaltrials.gov/ct2/show/record/NCT00814346?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=1 (Assessed on December 20, 2021)
  95. A study on the use of tanakan® for recovery of neurological impairment following ischaemic stroke.Available from: https://clinicaltrials.gov/ct2/show/record/NCT00276380?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=2 (Assessed on December 20, 2021)
  96. WuT. The first affiliated hospital with nanjing medical university. Clinical efficacy of GBE in the treatment of alzheimer's disease.Available from: https://clinicaltrials.gov/ct2/show/record/NCT03090516?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=3 (Assessed on December 20, 2021)
  97. StevenT. University of pittsburgh, department of neurology. Ginkgo biloba prevention trial in older individuals.Available from: https://clinicaltrials.gov/ct2/show/record/NCT00010803?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=4 (Assessed on December 20, 2021)
  98. Effect of EGb761® on patients with mild to moderate alzheimer's disease.Available from: https://clinicaltrials.gov/ct2/show/record/NCT00500500?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=5 (Assessed on December 20, 2021)
  99. EGb761 in the syndrome of MCI With concomitant CVD.Available from: https://clinicaltrials.gov/ct2/show/record/NCT04525144?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=6 (Assessed on December 20, 2021)
  100. Vida DemarinM.D. University Department of Neurology, Sestre milosrdnice University Hospital, Vinogradska 29, HR-10000 Zagreb, Croatia.Available from: https://clinicaltrials.gov/ct2/show/record/NCT00446485?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=7 (Assessed on December 20, 2021)
  101. Ginkgo diterpene lactone meglumine injection on platelet reactivity in acute ischemic stroke (GDPRS).Available from: https://clinicaltrials.gov/ct2/show/record/NCT03219645?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=9 (Assessed on December 20, 2021)
  102. A study of EGb761® (Tanakan®) in dementia of alzheimer type onset in patients suffering from memory complaints.Available from: https://clinicaltrials.gov/ct2/show/record/NCT00276510?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=10 (Assessed on December 20, 2021)
  103. BaumL. Chinese university of Hong Kong. A pilot study of curcumin and ginkgo for treating alzheimer's disease.Available from: https://clinicaltrials.gov/ct2/show/record/NCT00164749?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=12 (Assessed on December 20, 2021)
  104. Efficacy of EGb761 in patients suffering from friedreich ataxia.Available from: https://clinicaltrials.gov/ct2/show/record/NCT00824512?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=13 (Assessed on December 20, 2021)
  105. Treatment for Early Memory Loss.Available from: https://clinicaltrials.gov/ct2/show/record/NCT00042172?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=14 (Assessed on December 20, 2021)
  106. Piu ChanM.D. Treatment of depression in parkinson's disease.Available from: https://clinicaltrials.gov/ct2/show/study/NCT01416818?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=15 (Assessed on December 20, 2021)
  107. Janssen-CilagG.H. Long-term use of galantamine versus nootropics (memory enhancing drugs) in patients with alzheimer's dementia under conditions of dailyroutine.Available from: https://clinicaltrials.gov/ct2/show/record/NCT01009476?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=16 (Assessed on December 20, 2021)
  108. ZeX.C. Ginkgolide with intravenous alteplase thrombolysis in acute ischemic stroke neurological improving trial (GIANT).Available from: https://clinicaltrials.gov/ct2/show/record/NCT03772847?term=ginkgo+biloba&cond=Brain+Disorders&draw=2&rank=18 (Assessed on December 20, 2021)
  109. WangH.Y. ZhangY.Q. The main active constituents and detoxification process of Ginkgo biloba seeds and their potential use in functional health foods.J. Food Compos. Anal.20198310324710.1016/j.jfca.2019.103247
    [Google Scholar]
  110. KaraveliogluZ. Cakir-KocR. Preparation of chitosan nanoparticles as Ginkgo Biloba extract carrier: In vitro neuroprotective effect on oxidative stress-induced human neuroblastoma cells (SH-SY5Y).Int. J. Biol. Macromol.202119267568310.1016/j.ijbiomac.2021.10.02334655582
    [Google Scholar]
  111. LiL. StantonJ.D. TolsonA.H. LuoY. WangH. Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways.Pharm. Res.200926487288210.1007/s11095‑008‑9788‑819034627
    [Google Scholar]
  112. LimH.B. KimD.H. Effects of roasting conditions on physicochemical properties and antioxidant activities in Ginkgo biloba seeds.Food Sci. Biotechnol.20182741057106610.1007/s10068‑018‑0348‑730263835
    [Google Scholar]
  113. LiangW. XuW. ZhuJ. GBE improves brain uptake of ginsenosides by increasing blood-brain barrier permeability via activating the A1 adenosine receptor signaling pathway.J. Ethnopharmacol.202024611224310.1016/j.jep.2019.11224331541722
    [Google Scholar]
  114. ZhaoY. XiongS. LiuP. LiuW. WangQ. LiuY. TanH. ChenX. ShiX. WangQ. ChenT. Polymeric nanoparticles-based brain delivery with improved therapeutic efficacy of ginkgolide b in parkinson’s disease.Int. J. Nanomedicine202015104531046710.2147/IJN.S27283133380795
    [Google Scholar]
  115. BriskeyD. RaoA. A double-blind, randomised cross-over study to evaluate the absorption of a commercially available GBE compared to the liposomal extract Ginkgosome.BMC Complement Med Ther.202222120610.1186/s12906‑022‑03679‑x35922794
    [Google Scholar]
  116. PatilU.K. SaraogiR. Natural products as potential drug permeation enhancer in transdermal drug delivery system.Arch. Dermatol. Res.2014306541942610.1007/s00403‑014‑1445‑y24481830
    [Google Scholar]
  117. KimJ.S. LeeY.J. KimS.Y. KimS.J. A pharmaceutical composition comprising GBE and its use for treating tinnitus.U.S. Patent 8,728,7412014
  118. MatsumotoT. Health drink containing ginkgo extract.Patent JPH0563147B21993
  119. LeeS.J. ParkS.K. LeeC.H. A composition comprising GBE for treating skin disorders.U.S. Patent 8,486,4372013
  120. CaoF. Ecological basis for ginkgo agroforestry systems.China Forestry Publishing House. Ph.D. Thesis, The University of British Columbia, Vancouver, Canada, 20042007
    [Google Scholar]
  121. KimJ.S. LeeY.J. KimS.Y. KimS.J. Method for preparing GBE and its application in the treatment of hypertension.U.S. Patent 8, 518,8322013
  122. Patra, J.K.; Das, G.; Kumar, S.; Thatoi, H., Eds.; Ethnopharmacology and biodiversity of medicinal plants.CRC Press201910.1201/9780429398193
    [Google Scholar]
  123. SehgalV.K. Climate, agriculture, and man shrinking biodiversity and sustainability.Scientific Publishers2019
    [Google Scholar]
  124. Di MarinoG. ToselliF. FidanzaP. Compositions comprising a GBE and methods of use thereof.U.S. Patent 10,291,1052019
  125. KimH.J. KimY.J. KimD.S. GBE-containing composition for improving cerebral blood flow.U.S. Patent 9,610,2682017
  126. BaeJ.Y. LeeC.W. KimJ. Topical composition containing GBE for skin aging.U.S. Patent 9,351,9342016
  127. BucciL.R. YangZ. MaroneP.A. GBEs enriched in flavone glycosides and methods of use thereof.U.S. Patent 8,114,3812012
  128. SticherO. BommerS. BosR. Methods for producing a GBE enriched in bilobalide and ginkgolides A, B, and C.U.S. Patent 7,931,0992011
  129. SastreJ. PallardóF.V. ViñaJ. Droy-LefaixM.T. GBE for the treatment of Alzheimer's disease.U.S. Patent 7,553,5782009
  130. KuhnertN. JerezM. VoinovichD. Method for producing a standardized extract of Ginkgo biloba leaves.U.S. Patent 7,270,8022007
  131. AlanJ. GBE for the treatment of erectile dysfunction.U.S. Patent 6,984,4702006
  132. KimS.H. KimS.H. KimS.J. Extract Ginkgo biloba and ginger for the treatment of vertigo.U.S. Patent 6,756,0452004
  133. CaiY. HuangC. WuL. ZhangS. GBE for the treatment of respiratory disease.U.S. Patent 6,656,9352003
  134. WangS. ChenZ. XingD. GBE for the treatment of diabetes.U.S. Patent 6,559,1262003
  135. CordeiroM.F. GuoL. AllenC. YeC. GBE for the treatment of glaucoma.U.S. Patent 6,416,7572002
  136. DrewS. DaviesE. LaceyJ. GBE for the treatment of tinnitus.U.S. Patent 6,342,2202002
  137. JohnsonE.S. SmithD.L. AlbrechtC. GBE for the treatment of migraine headache.U.S. Patent 6,165,5052002
  138. WangL. GuoT.L. VerpoorteR. GBE for the treatment of male infertility.U.S. Patent 5,902,7751999
  139. ZhangQ. LiZ. ChenZ. ZhanR. LiX. Method for producing a high-purity GBE.U.S. Patent 10,933,0792021
  140. WangY. LiH. FuL. GaoX. Method for extracting Ginkgo biloba leaves using a low-pressure water extraction process.U.S. Patent 10,864,9372020
  141. HanX. HanJ. KangY. KwonK. Pharmaceutical composition for improving cognitive function comprising GBE.U.S. Patent 10, 690, 112020
  142. ZhuX. LiuQ. ChenX. Method for preparing GBE and its application in the treatment of Alzheimer's disease.U.S. Patent 10,619,7262020
  143. YanL. SunG. GuoZ. Method for preparing GBE using a multi-stage extraction process.U.S. Patent 10,452,5652019
  144. BlumenkrantzN. BlumenkrantzR. Composition containing GBE and methods for its preparation.U.S. Patent 10,333,2172019
  145. YangW.S. LeeY.M. LeeJ.H. YooK.H. Transdermal delivery of GBE for treating alopecia.U.S. Patent 10, 675,4552020
  146. KimM.S. Pharmaceutical composition comprising GBE for treating benign prostatic hyperplasia.U.S. Patent 10, 573,0302020
  147. KimM.S. Ophthalmic pharmaceutical compositions comprising GBE.U.S. Patent 10,323,2592019
  148. KimM.S. Pharmaceutical composition comprising GBE for treating liver diseases.U.S. Patent 9,988,4732018
  149. KimM.S. Pharmaceutical composition comprising GBE for treating atopic dermatitis.U.S. Patent 9,861,7552017
  150. KimM.S. Pharmaceutical composition comprising GBE for treating chronic fatigue syndrome.U.S. Patent 9,345,6232016
  151. KimJ.S. LeeY.J. KimS.Y. KimS.J. ChungB.C. A pharmaceutical composition comprising GBE for treating chronic fatigue syndrome.U.S. Patent 8,911,9282014
  152. KimJ.S. LeeY.J. KimS.Y. KimS.J. A pharmaceutical composition comprising GBE and its use for treating macular degeneration.U.S. Patent 8,790,8242014
  153. KimJ.S. LeeY.J. KimS.Y. KimS.J. Method for preparing GBE and its application in the treatment of Osteoporosis.U.S. Patent 8,697,3722014
/content/journals/cnsamc/10.2174/0118715249362016250401085542
Loading
/content/journals/cnsamc/10.2174/0118715249362016250401085542
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keyword(s): antioxidant; bilobalide; bioactive; flavonoids; Ginkgo biloba; ginkgolides
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test